Meet us at ASN Kidney Week 2019

08. Oct 2019 | 3 min read

Meet us at ASN Kidney Week 2019

"Serum and plasma cystatin C measurement - a fast, easy and reliable estimation of renal function

Gentian at ASN Kidney Week 2019


We look forward to exhibit at ASN Kidney Week 2019 and we hope to see you in Washington, DC from November 7th to 9th  to discuss cystatin C and kidney health.

Cystatin C is a superior kidney marker and can be used to estimate GFR for patients independently of gender, weight and muscle mass. Cystatin C is recommended by KDIGO and NICE [1-3].

 

Visit us at booth #2133 - ASN Kidney week 2019


Gaute Tangen, Product Manager Cystatin C, and Shanyil Wickramasinghe, US Product Specialist, will be present at booth #2133 to tell you more about our cystatin C immunoassay and cystatin C in the clinical setting.

Want to know more? Book a meeting in advance through marketing@gentian.com

 

Gentian Cystatin C Immunoassay - FDA510(k) cleared

  • The Gentian Cystatin C Immunoassay is ERM-DA471 and IFCC standardised. The Gentian Cystatin C Immunoassay is FDA510(k) cleared and also CE-marked.

  • The immunoassay is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of cystatin C in human plasma and serum samples. It performs in 10 minutes.

  • The Gentian Cystatin C Immunoassay is used on a wide range of clinical chemistry analysers with documented high inter instrument accuracy [4].

Learn more about cystatin C

 

AACC WEBINAR ABOUT BIOMARKERS IN CHRONIC KIDNEY DISEASE:

The Use of Biomarkers in Chronic Kidney Disease and the Novel Disorder Shrunken Pore Syndrome

LEARN MORE ABOUT GENTIAN'S CYSTATIN C IMMUNOASSAY FOR PLASMA AND SERUM:

Gentian Cystatin C Immunoassay

INTERVIEW WITH DR. A. GRUBB – CYSTATIN C, GFR AND SPS:

Meet Dr. Grubb

 

References

[1] O.Z. Ismail, et al., 2017, http://dx.doi.org/10.1016/j.clinbiochem.2017.01.005

[2] Tangri N, et al Kidney Int 2011;79:471-7

[3] NCIC Clinical guideline (CG182) updated jan 2014 section 2.1  https://www.nice.org.uk/guidance/cg182/chapter/2-Implementation-getting-started

[4] Eckfeldt JH, et al. 2014 CYS Survey. Arch Pathol Lab Med 2015;139:888-93

You may also read


#FAQ: Avian antibodies – Immunoglobulin Y(IgY)

Jan 23, 2020

#FAQ: Avian antibodies – Immunoglobulin Y(IgY)

Avian antibodies in our commercial products since 2005 Gentian has applied avian antibodies with great..

CEO Interview at Arctic Securities

Jan 17, 2020

CEO Interview at Arctic Securities

Our CEO Dr. Hilja Ibert recently sat down with Pål Falck in Arctic Securities to have a look at Gentian's..

Diagnostic Efficiency by Gentian - Newsletter H1-2020

Jan 14, 2020

Diagnostic Efficiency by Gentian - Newsletter H1-2020

  Happy New Year 2020 We look forward to exhibiting at and visiting numerous trade shows and congresses..